a randomized Phase 3 trial of TH-302 in patients with advanced first-line pancreatic cancer is planned to be initiated together with our partner Merck KGaA. We are grateful to the clinical ...

Cayman Islands, January 28, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi ...

DEAR MAYO CLINIC: My uncle recently passed away from pancreatic cancer. My mom keeps saying how important it is for us to get screened for it. I’m still young. Do I need to go through screening?

This valuable study on Pseudomonas subverting host immunity identifies a new immune evasion strategy. There is solid evidence for the cleavage of VgrG2B by Caspase 11 and the generation of fragments ...

Band intensities of cleaved caspase-11 (top) and GSDMD (bottom) were quantified and compared to that of ... (B) Wild-type BMDM cells were infected with lentiviruses encoding a control vector or VgrG2b ...

Basketball Hall of Famer and three-time NBA champion Dwyane Wade had a cancerous tumor removed from his right kidney in 2023, he revealed Thursday on his podcast. Wade, 43, said doctors removed 40 ...

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their ... Researchers Pioneer DNA ...

Objective Investigating the effect of ferroptosis in the tumour microenvironment to identify combinatory therapy for liver cancer treatment. Design Glutathione peroxidase 4 (GPx4), which is considered ...

The three-signal paradigm tries to capture how the innate immune system instructs adaptive immune responses in three well-defined actions: (1) presentation of antigenic peptides in the context of MHC ...

That is approved for melanoma, but failed a phase 3 trial in MSS colorectal cancer last year. "Following a careful analysis of the data, the decision has been made to discontinue development of ...